Susquehanna International Group’s Plus Therapeutics PSTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,691
Closed -$46K 13342
2025
Q3
$46K Buy
+2,691
New +$33K ﹤0.01% 11883
2025
Q2
Sell
-3,220
Closed -$76.5K 13502
2025
Q1
$76.5K Buy
+3,220
New +$90K ﹤0.01% 11694
2022
Q4
Sell
-123
Closed -$21K 13412
2022
Q3
$21K Buy
+123
New +$27.5K ﹤0.01% 12589
2022
Q2
Sell
-29
Closed -$11K 13724
2022
Q1
$11K Sell
29
-59
-67% -$22.4K ﹤0.01% 12740
2021
Q4
$35K Buy
+88
New +$50.7K ﹤0.01% 12700
2019
Q4
Sell
-78
Closed -$101K 10434
2019
Q3
$101K Buy
78
+76
+3,800% +$275K ﹤0.01% 9552
2019
Q2
$10K Buy
+2
New +$10.3K ﹤0.01% 10078
2018
Q2
Hold
0
10231
2018
Q1
Hold
0
9132
2017
Q4
Hold
0
9049
2017
Q3
Hold
0
8688
2015
Q3
Sell
-2
Closed -$3.79M 10046
2015
Q2
$3.79M Buy
+2
New +$4.58M ﹤0.01% 3410
2015
Q1
Hold
0
-$61K 9828
2014
Q4
Hold
0
9323
2014
Q3
Hold
0
9337
2014
Q2
Hold
0
8321
2014
Q1
Hold
0
7240
2013
Q4
Hold
0
7647
2013
Q3
Hold
0
8686
2013
Q2
Hold
0
7197

Other funds holding PSTV

Susquehanna International Group's PSTV Position: Q4 2025 in Review

Susquehanna International Group sold out of Plus Therapeutics (PSTV) in Q4 2025, closing a stake of 2,691 shares — an estimated $46K sold.

Susquehanna International Group first reported a position in PSTV in Q2 2015 and held it in 8 quarters. The position peaked at $3.79M in Q2 2015. 25 funds tracked by Wall St. Rank hold PSTV as of Q4 2025.

  • Susquehanna International Group reported no remaining Plus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,691 Plus Therapeutics shares in Q4 2025, an estimated $46K.
  • Susquehanna International Group first reported a position in Plus Therapeutics in Q2 2015 and held it in 8 quarters.
  • Susquehanna International Group's Plus Therapeutics position peaked at $3.79M in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Plus Therapeutics as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.